Prospective studies, experimental validation in diverse cancer types, and mechanistic investigations are essential to deepen our understanding of KANK2's functional roles and therapeutic potential, ultimately enhancing its translational impact as a biomarker and therapeutic target in oncology. This evidence concerns the gene KANK2 and cancer.